ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/12/07 | 4,720 | 4,770 | 4,615 | 4,755 | +140 | +3% | 813,200 |
2018/12/06 | 4,765 | 4,795 | 4,535 | 4,615 | -195 | -4.1% | 1,009,900 |
2018/12/05 | 4,705 | 4,830 | 4,625 | 4,810 | +100 | +2.1% | 1,194,500 |
2018/12/04 | 4,665 | 4,850 | 4,660 | 4,710 | +35 | +0.7% | 1,238,300 |
2018/12/03 | 4,720 | 4,760 | 4,645 | 4,675 | +25 | +0.5% | 722,800 |
2018/11/30 | 4,605 | 4,680 | 4,560 | 4,650 | +10 | +0.2% | 647,100 |
2018/11/29 | 4,630 | 4,720 | 4,570 | 4,640 | +40 | +0.9% | 874,700 |
2018/11/28 | 4,500 | 4,650 | 4,490 | 4,600 | +135 | +3% | 1,046,400 |
2018/11/27 | 4,495 | 4,540 | 4,435 | 4,465 | +20 | +0.4% | 737,900 |
2018/11/26 | 4,500 | 4,510 | 4,380 | 4,445 | -20 | -0.4% | 557,400 |
2018/11/22 | 4,395 | 4,470 | 4,355 | 4,465 | +70 | +1.6% | 509,200 |
2018/11/21 | 4,315 | 4,450 | 4,305 | 4,395 | -20 | -0.5% | 458,700 |
2018/11/20 | 4,455 | 4,515 | 4,385 | 4,415 | -105 | -2.3% | 593,300 |
2018/11/19 | 4,330 | 4,550 | 4,325 | 4,520 | +245 | +5.7% | 1,168,000 |
2018/11/16 | 4,360 | 4,410 | 4,270 | 4,275 | -60 | -1.4% | 585,400 |
2018/11/15 | 4,200 | 4,360 | 4,145 | 4,335 | +65 | +1.5% | 726,600 |
2018/11/14 | 4,410 | 4,450 | 4,250 | 4,270 | -135 | -3.1% | 910,300 |
2018/11/13 | 4,200 | 4,415 | 4,175 | 4,405 | +10 | +0.2% | 1,089,800 |
2018/11/12 | 4,365 | 4,425 | 4,305 | 4,395 | -5 | -0.1% | 873,600 |
2018/11/09 | 4,340 | 4,435 | 4,335 | 4,400 | +75 | +1.7% | 1,028,100 |
2018/11/08 | 4,300 | 4,385 | 4,210 | 4,325 | +190 | +4.6% | 1,092,500 |
2018/11/07 | 4,075 | 4,170 | 4,035 | 4,135 | +70 | +1.7% | 905,200 |
2018/11/06 | 3,980 | 4,075 | 3,935 | 4,065 | +190 | +4.9% | 835,900 |
2018/11/05 | 3,915 | 4,045 | 3,875 | 3,875 | -110 | -2.8% | 787,000 |
2018/11/02 | 3,700 | 4,005 | 3,675 | 3,985 | +345 | +9.5% | 1,473,700 |
2018/11/01 | 3,720 | 3,730 | 3,590 | 3,640 | -65 | -1.8% | 1,008,400 |
2018/10/31 | 3,535 | 3,710 | 3,470 | 3,705 | +195 | +5.6% | 1,126,300 |
2018/10/30 | 3,390 | 3,540 | 3,290 | 3,510 | -20 | -0.6% | 2,150,000 |
2018/10/29 | 3,715 | 3,745 | 3,520 | 3,530 | -215 | -5.7% | 1,557,700 |
2018/10/26 | 4,040 | 4,050 | 3,655 | 3,745 | -225 | -5.7% | 2,173,400 |
2018/10/25 | 4,215 | 4,225 | 3,960 | 3,970 | -415 | -9.5% | 1,359,700 |
2018/10/24 | 4,335 | 4,415 | 4,265 | 4,385 | +100 | +2.3% | 541,100 |
2018/10/23 | 4,450 | 4,450 | 4,265 | 4,285 | -230 | -5.1% | 701,400 |
2018/10/22 | 4,490 | 4,535 | 4,385 | 4,515 | +65 | +1.5% | 668,800 |
2018/10/19 | 4,350 | 4,460 | 4,320 | 4,450 | +65 | +1.5% | 836,100 |
2018/10/18 | 4,390 | 4,430 | 4,355 | 4,385 | +55 | +1.3% | 702,700 |
2018/10/17 | 4,240 | 4,345 | 4,230 | 4,330 | +235 | +5.7% | 836,000 |
2018/10/16 | 4,125 | 4,185 | 4,050 | 4,095 | -30 | -0.7% | 519,400 |
2018/10/15 | 4,210 | 4,220 | 4,110 | 4,125 | -135 | -3.2% | 638,800 |
2018/10/12 | 4,170 | 4,270 | 4,135 | 4,260 | +55 | +1.3% | 752,400 |
2018/10/11 | 4,110 | 4,225 | 4,090 | 4,205 | -110 | -2.5% | 799,200 |
2018/10/10 | 4,375 | 4,415 | 4,280 | 4,315 | +40 | +0.9% | 602,700 |
2018/10/09 | 4,390 | 4,420 | 4,255 | 4,275 | -215 | -4.8% | 817,900 |
2018/10/05 | 4,565 | 4,570 | 4,465 | 4,490 | -165 | -3.5% | 602,400 |
2018/10/04 | 4,655 | 4,730 | 4,625 | 4,655 | ±0 | ±0% | 597,400 |
2018/10/03 | 4,660 | 4,710 | 4,640 | 4,655 | -70 | -1.5% | 700,300 |
2018/10/02 | 4,690 | 4,750 | 4,595 | 4,725 | +100 | +2.2% | 1,160,100 |
2018/10/01 | 4,580 | 4,665 | 4,570 | 4,625 | +95 | +2.1% | 910,900 |
2018/09/28 | 4,490 | 4,575 | 4,485 | 4,530 | +65 | +1.5% | 802,200 |
2018/09/27 | 4,520 | 4,570 | 4,465 | 4,465 | -40 | -0.9% | 733,100 |
1551~
1600
件表示中 / 2899件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 187,600円 | +5.0% | +1.5% | 0.00% | 16.10倍 | 4.28倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 357,000円 | +7.9% | +8.9% | 3.47% | 7.64倍 | 1.02倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 62,700円 | +21.1% | - | 0.00% | 15.57倍 | 2.18倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 410,900円 | +30.5% | +111.0% | 4.62% | 11.58倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 378,000円 | +14.5% | -2.3% | 2.38% | 13.83倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム